Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $98.9000 (-4.22%) ($96.8200 - $102.8500) on Thu. Sep. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.52% (three month average) | RSI | 24 | Latest Price | $98.9000(-4.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.8% a day on average for past five trading days. | Weekly Trend | LGND declines -5.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.26% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.26% (StdDev 2.52%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $109.36 | 5 Day Moving Average | $101.87(-2.92%) | 10 Day Moving Average | $104.36(-5.23%) | 20 Day Moving Average | $109.36(-9.56%) | To recent high | -22% | To recent low | 0% | Market Cap | $1.589b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |